BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1508 related articles for article (PubMed ID: 947930)

  • 1. Changes in serum triiodothyronine, thyroxine, and thyrotropin during treatment with thyroxine in severe primary hypothyroidism.
    Maeda M; Kuzuya N; Masuyama Y; Imai Y; Ikeda H
    J Clin Endocrinol Metab; 1976 Jul; 43(1):10-7. PubMed ID: 947930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seasonal variation of serum thyrotropin concentration and thyrotropin response to thyrotropin-releasing hormone in patients with primary hypothyroidism on constant replacement dosage of thyroxine.
    Konno N; Morikawa K
    J Clin Endocrinol Metab; 1982 Jun; 54(6):1118-24. PubMed ID: 6804476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of serum thyrotropin (TSH) to the thyroid hormones after oral TSH-releasing hormone in patients with preclinical hypothyroidism.
    Staub JJ; Noelpp B; Gräni R; Gemsenjäger E; Hauenstein M; Girard J
    J Clin Endocrinol Metab; 1983 Mar; 56(3):449-53. PubMed ID: 6401757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The comparative effect of T4 and T3 on the TSH response to TRH in young adult men.
    Sawin CT; Hershman JM; Chopra IJ
    J Clin Endocrinol Metab; 1977 Feb; 44(2):273-8. PubMed ID: 402379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patterns off recovery of the hypothalamic-pituitary-thyroid axis in patients taken of chronic thyroid therapy.
    Krugman LG; Hershman JM; Chopra IJ; Levine GA; Pekary E; Geffner DL; Chua Teco GN
    J Clin Endocrinol Metab; 1975 Jul; 41(1):70-80. PubMed ID: 807596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the nocturnal serum thyrotropin (TSH) surge, as assessed by TSH ultrasensitive assay, in patients receiving long term L-thyroxine suppression therapy and in patients with various thyroid disorders.
    Bartalena L; Martino E; Falcone M; Buratti L; Grasso L; Mammoli C; Pacchiarotti A; Aghini-Lombardi F; Balzano S; Pinchera A
    J Clin Endocrinol Metab; 1987 Dec; 65(6):1265-71. PubMed ID: 3680483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of thyrotropin responses to thyrotropin-releasing hormone following small decreases in serum thyroid hormone concentrations.
    Saberi M; Utiger RD
    J Clin Endocrinol Metab; 1975 Mar; 40(3):435-41. PubMed ID: 803974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response.
    Snyder PJ; Utiger RD
    J Clin Invest; 1973 Sep; 52(9):2305-12. PubMed ID: 4199417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum thyroid hormone and thyrotropin levels in subjects from endemic goiter regions of New Guinea.
    Chopra IJ; Hershman JM; Hornabrook RW
    J Clin Endocrinol Metab; 1975 Feb; 40(2):326-33. PubMed ID: 1117981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of serum total thyroxine, triiodothyronine, free thyroxine, and thyrotropin concentrations for diagnosis of hypothyroidism in dogs.
    Peterson ME; Melián C; Nichols R
    J Am Vet Med Assoc; 1997 Dec; 211(11):1396-402. PubMed ID: 9394888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The TSH response to thyrotropin-releasing hormone (TRH) in young adult men: intra-individual variation and relation to basal serum TSH and thyroid hormones.
    Sawin CT; Hershman JM
    J Clin Endocrinol Metab; 1976 May; 42(5):809-16. PubMed ID: 818102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Free thyroid hormones in evaluating persistently elevated thyrotropin levels in children with congenital hypothyroidism on replacement therapy.
    Focarile F; Rondanini GF; Bollati A; Bartolucci A; Chiumello G
    J Clin Endocrinol Metab; 1984 Dec; 59(6):1211-4. PubMed ID: 6490797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum thyrotropin and prolactin in the syndrome of generalized resistance to thyroid hormone: responses to thyrotropin-releasing hormone stimulation and short term triiodothyronine suppression.
    Sarne DH; Sobieszczyk S; Ain KB; Refetoff S
    J Clin Endocrinol Metab; 1990 May; 70(5):1305-11. PubMed ID: 2110573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replacement therapy with levothyroxine plus triiodothyronine (bioavailable molar ratio 14 : 1) is not superior to thyroxine alone to improve well-being and cognitive performance in hypothyroidism.
    Siegmund W; Spieker K; Weike AI; Giessmann T; Modess C; Dabers T; Kirsch G; Sänger E; Engel G; Hamm AO; Nauck M; Meng W
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):750-7. PubMed ID: 15163340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low serum triiodothyronine (T3) and hypothyroidism in anorexia nervosa.
    Croxson MS; Ibbertson HK
    J Clin Endocrinol Metab; 1977 Jan; 44(1):167-74. PubMed ID: 401822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-related change in pituitary threshold for TSH release during thyroxine replacement therapy for cretinism.
    Sato T; Suzuki Y; Taketani T; Ishiguro K; Nakajima H
    J Clin Endocrinol Metab; 1977 Mar; 44(3):553-9. PubMed ID: 402383
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low setting of feedback regulation of TSH secretion by thyroxine in pituitary dwarfism with TSH-releasing hormone deficiency.
    Sato T; Ishiguro K; Suzuki Y; Taketani T; Isumisawa A
    J Clin Endocrinol Metab; 1976 Feb; 42(2):385-90. PubMed ID: 816807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normal thyroxine and elevated thyrotropin concentrations: evolving hypothyroidism or persistent euthyroidism with reset thyrostat.
    Kabadi UM; Cech R
    J Endocrinol Invest; 1997 Jun; 20(6):319-26. PubMed ID: 9294777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship of serum T4 and T3 to TSH in primary hypothyroidism.
    Ryder S; Gollapudi GM; Varma A
    Arch Intern Med; 1980 Oct; 140(10):1290-1. PubMed ID: 6775609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to thyrotropin releasing hormone: an objective criterion for the adequacy of thyrotropin suppression therapy.
    Hoffman DP; Surks MI; Oppenheimer JH; Weitzman ED
    J Clin Endocrinol Metab; 1977 May; 44(5):892-901. PubMed ID: 404309
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 76.